Skip to main content
. 2016 Aug 2;7(50):82338–82353. doi: 10.18632/oncotarget.11001

Table 1. The demographic and clinicopathologic characteristics of the patients with pancreatic ductal adenocarcinoma treated by surgical resection.

Characteristics Patients for the miRNA microarray Patients of the evaluation
cohort (n)
Good prognosis group Poor prognosis group P value
No. Patients 10 10 114
Age (years)          < 60 4 6 0.371 55 (48.2%)
               ≥ 60 6 4 59 (51.8%)
Gender            Male 4 6 0.371 68 (59.6%)
               Female 6 4 46 (40.4%)
Location of tumor      Head 8 9 0.500 88 (77.2%)
               Body or tail 2 1 26 (22.8%)
Type of operation   Pancreaticoduodenectomy 8 8 0.709 88 (77.2%)
         Distal pancreatectomy 2 2 25 (21.9%)
        Total pancreatectomy 0 0 1 (0.9%)
Maximum tumor diameter (mean ± SD) (cm) 4.35 ± 1.23 4.75 ± 1.44 0.512 4.22 ± 1.81
Differenciation        Well 4 3 0.881 40 (35.1%)
           Moderately 4 5 57 (50.0%)
        Poor 2 2 17 (14.9%)
Surgical margins       Negative 9 10 0.500 111 (97.4%)
               Positive 1 0 3 (2.6%)
pT category          pT1+ pT2 4 3 0.500 58 (50.9%)
               pT3+pT4 6 7 56 (49.1%)
pN category          pN0 4 4 0.675 84 (73.7%)
               pN1 6 6 30 (26.3%)
Vessel invasion        No 5 3 0.325 61 (53.5%)
               Yes 5 7 53 (46.5%)
Vascular tumor thrombus   No 10 10 --- 111 (97.4%)
               Yes 0 0 3 (2.6%)
Adjacent organs invasion  No 7 8 0.500 86 (75.4%)
               Yes 3 2 28 (24.6%)
pTNM category        I 0 0 0.675 53 (46.4%)
       IIA 4 4 15 (13.2%)
       IIB 6 6 18 (15.8%)
      III 0 0 28 (24.6%)
CA19-9 (median, range) (U/mL) 250.0
(9.69–739.70)
130.40
(0.6–1551)
0.791 287.61
(0.60–12076.00)